| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | ATP13A4 SPNS1 SLC25A21 SLC16A13 SLC2A9 SLC2A7 SLC43A1 SLC22A15 SLCO1B3 ABCA7 SLC4A1 PITPNM1 SLC6A7 CNNM3 SLC7A4 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 SLC22A8 CLCN6 CLCA2 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 TMEM41B SLC14A2 SLC23A1 SLC16A8 SLC23A3 | 1.16e-12 | 1289 | 137 | 35 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP13A4 SPNS1 SLC25A21 SLC16A13 SLC2A9 SLC2A7 SLC43A1 SLC22A15 SLCO1B3 ABCA7 SLC4A1 SLC6A7 CNNM3 SLC7A4 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 SLC22A8 CLCN6 CLCA2 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 SLC14A2 SLC23A1 SLC16A8 SLC23A3 | 2.70e-12 | 1180 | 137 | 33 | GO:0022857 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A21 SLC16A13 SLC2A9 SLCO1B3 SLC4A1 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 SLC22A8 CLCN6 SLC5A6 SLC5A8 SLC23A1 SLC16A8 | 2.14e-10 | 296 | 137 | 16 | GO:0015291 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP13A4 SLC25A21 SLC16A13 SLC2A9 SLCO1B3 ABCA7 SLC4A1 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 SLC22A8 CLCN6 SLC5A6 SLC5A8 SLC23A1 SLC16A8 | 4.78e-09 | 477 | 137 | 18 | GO:0022804 |
| GeneOntologyMolecularFunction | symporter activity | SLC16A13 SLC2A9 SLC6A7 SLC46A3 SLC12A1 SLC12A3 SLC5A6 SLC5A8 SLC23A1 SLC16A8 | 8.59e-08 | 150 | 137 | 10 | GO:0015293 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP13A4 SLC2A9 SLC4A1 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 SLC22A8 CLCN6 CLCA2 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 SLC23A1 | 2.39e-07 | 758 | 137 | 20 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ATP13A4 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 SLC23A1 | 7.41e-07 | 465 | 137 | 15 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP13A4 SLC2A9 SLC4A1 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 CLCN6 CLCA2 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 SLC23A1 | 2.07e-06 | 793 | 137 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 2.31e-06 | 167 | 137 | 9 | GO:0015079 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC25A21 SLC16A13 SLC43A1 SLCO1B3 SLC4A1 SLC6A7 SLC22A8 SLC5A6 SLC5A8 SLC23A1 SLC16A8 | 5.80e-06 | 293 | 137 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP13A4 SLC2A9 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 SLC23A1 | 6.47e-06 | 627 | 137 | 16 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP13A4 SLC2A9 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 SLC23A1 | 1.32e-05 | 664 | 137 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC25A21 SLC16A13 SLC43A1 SLCO1B3 SLC6A7 SLC5A6 SLC5A8 SLC23A1 SLC16A8 | 1.32e-05 | 207 | 137 | 9 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC25A21 SLC16A13 SLC43A1 SLCO1B3 SLC6A7 SLC5A6 SLC5A8 SLC23A1 SLC16A8 | 1.38e-05 | 208 | 137 | 9 | GO:0005342 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.81e-05 | 119 | 137 | 7 | GO:0015294 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.99e-05 | 81 | 137 | 6 | GO:0015370 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 2.40e-05 | 171 | 137 | 8 | GO:0015081 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP13A4 SLC2A9 SLC4A1 SLC6A7 SLC9A4 SLC12A1 SLC12A3 SLC5A6 SLC5A8 SLC23A1 | 4.43e-05 | 301 | 137 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 7.33e-05 | 102 | 137 | 6 | GO:0005249 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 9.41e-05 | 35 | 137 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | sodium:potassium:chloride symporter activity | 1.40e-04 | 3 | 137 | 2 | GO:0008511 | |
| GeneOntologyMolecularFunction | potassium:sodium symporter activity | 1.40e-04 | 3 | 137 | 2 | GO:0009674 | |
| GeneOntologyMolecularFunction | phosphatidate cytidylyltransferase activity | 1.40e-04 | 3 | 137 | 2 | GO:0004605 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 1.81e-04 | 171 | 137 | 7 | GO:0015103 | |
| GeneOntologyMolecularFunction | potassium channel activity | 2.55e-04 | 128 | 137 | 6 | GO:0005267 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.65e-04 | 182 | 137 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.83e-04 | 184 | 137 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 3.89e-04 | 90 | 137 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 6.17e-04 | 151 | 137 | 6 | GO:0008509 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 6.39e-04 | 152 | 137 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | lactate transmembrane transporter activity | 6.88e-04 | 6 | 137 | 2 | GO:0015129 | |
| GeneOntologyMolecularFunction | monosaccharide transmembrane transporter activity | 8.19e-04 | 27 | 137 | 3 | GO:0015145 | |
| GeneOntologyMolecularFunction | sugar transmembrane transporter activity | 1.01e-03 | 29 | 137 | 3 | GO:0051119 | |
| GeneOntologyMolecularFunction | fructose transmembrane transporter activity | 1.63e-03 | 9 | 137 | 2 | GO:0005353 | |
| GeneOntologyMolecularFunction | urate transmembrane transporter activity | 1.63e-03 | 9 | 137 | 2 | GO:0015143 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 1.63e-03 | 9 | 137 | 2 | GO:0015379 | |
| GeneOntologyMolecularFunction | salt transmembrane transporter activity | 1.63e-03 | 9 | 137 | 2 | GO:1901702 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.72e-03 | 125 | 137 | 5 | GO:0015108 | |
| GeneOntologyMolecularFunction | cytidylyltransferase activity | 2.03e-03 | 10 | 137 | 2 | GO:0070567 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.18e-03 | 334 | 137 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.35e-03 | 196 | 137 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.56e-03 | 83 | 137 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.64e-03 | 138 | 137 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization | 2.95e-03 | 12 | 137 | 2 | GO:1902282 | |
| GeneOntologyMolecularFunction | carbohydrate transmembrane transporter activity | 2.98e-03 | 42 | 137 | 3 | GO:0015144 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.98e-03 | 42 | 137 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 4.03e-03 | 14 | 137 | 2 | GO:0015132 | |
| GeneOntologyBiologicalProcess | CDP-diacylglycerol biosynthetic process | 1.35e-06 | 13 | 139 | 4 | GO:0016024 | |
| GeneOntologyBiologicalProcess | CDP-diacylglycerol metabolic process | 1.88e-06 | 14 | 139 | 4 | GO:0046341 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | SLC4A1 SLC12A1 SLC12A3 SLC22A8 CLCN6 CLCA2 SLC5A6 KCNQ1 SLC5A8 | 3.72e-06 | 180 | 139 | 9 | GO:0015698 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP13A4 ZMPSTE24 SLC2A9 PARK7 SLC22A15 SLCO1B3 SLC4A1 SLC6A7 CNNM3 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 SLC22A8 CLCN6 CLCA2 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 SLC23A1 | 4.80e-06 | 1374 | 139 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | organic anion transport | SLC25A21 SLC16A13 SLC2A9 SLC43A1 SLCO1B3 SLC4A1 SLC6A7 SLC22A8 SLC5A6 SLC5A8 G6PC1 NOS2 SLC23A1 SLC16A8 | 1.04e-05 | 515 | 139 | 14 | GO:0015711 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC6A7 SLC9A4 SLC12A1 SLC12A3 SLC5A6 SCN2B KCNQ1 KCNQ2 SLC23A1 | 1.20e-05 | 208 | 139 | 9 | GO:0035725 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | ATP13A4 SLC2A9 PARK7 SLC4A1 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 CLCN6 CLCA2 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC5A8 SLC23A1 | 1.61e-05 | 1017 | 139 | 20 | GO:0098660 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC6A7 SLC9A4 SLC12A1 SLC12A3 SLC5A6 SCN2B KCNQ1 KCNQ2 SLC5A8 SLC23A1 | 1.77e-05 | 275 | 139 | 10 | GO:0006814 |
| GeneOntologyBiologicalProcess | amide transport | CWH43 PARK7 SLCO1B3 F2RL1 SLC12A1 SLC22A8 SLC5A6 KCNQ1 UPK3A SLC14A2 NOS2 IL6 | 2.82e-05 | 420 | 139 | 12 | GO:0042886 |
| GeneOntologyBiologicalProcess | lipid localization | SPNS1 CDS1 SLC25A21 CDS2 SLCO1B3 ABCA7 SLC4A1 PITPNM1 SLC22A8 KCNQ1 SLC5A8 TMEM41B NOS2 IL6 | 2.90e-05 | 565 | 139 | 14 | GO:0010876 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.45e-05 | 183 | 139 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | 3.49e-05 | 134 | 139 | 7 | GO:0098661 | |
| GeneOntologyBiologicalProcess | iodide transport | 4.75e-05 | 11 | 139 | 3 | GO:0015705 | |
| GeneOntologyBiologicalProcess | urea transport | 1.03e-04 | 14 | 139 | 3 | GO:0015840 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | SLC25A21 SLC16A13 SLC43A1 SLCO1B3 SLC6A7 SLC22A8 SLC5A6 SLC5A8 NOS2 SLC23A1 SLC16A8 | 1.07e-04 | 410 | 139 | 11 | GO:0046942 |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 1.10e-04 | 37 | 139 | 4 | GO:0055075 | |
| GeneOntologyBiologicalProcess | import into cell | IL10RA FKBP15 PARK7 SLC43A1 POT1 ITGAM F2RL1 DENND1A ABCA7 SLC6A7 SLC9A4 SLC12A1 SLC12A3 PROM2 SLC5A6 KCNQ1 KCNQ2 KCNQ3 DLG4 | 1.10e-04 | 1074 | 139 | 19 | GO:0098657 |
| GeneOntologyBiologicalProcess | organic acid transport | SLC25A21 SLC16A13 SLC43A1 SLCO1B3 SLC6A7 SLC22A8 SLC5A6 SLC5A8 NOS2 SLC23A1 SLC16A8 | 1.12e-04 | 412 | 139 | 11 | GO:0015849 |
| GeneOntologyBiologicalProcess | glycerophospholipid biosynthetic process | 1.14e-04 | 217 | 139 | 8 | GO:0046474 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.21e-04 | 163 | 139 | 7 | GO:1905039 | |
| GeneOntologyBiologicalProcess | substantia propria of cornea development | 1.35e-04 | 3 | 139 | 2 | GO:1903701 | |
| GeneOntologyBiologicalProcess | apoptosome assembly | 1.35e-04 | 3 | 139 | 2 | GO:0097314 | |
| GeneOntologyBiologicalProcess | regulation of action potential firing threshold | 1.35e-04 | 3 | 139 | 2 | GO:0099611 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 1.40e-04 | 167 | 139 | 7 | GO:1903825 | |
| GeneOntologyBiologicalProcess | regulation of collagen metabolic process | 1.73e-04 | 77 | 139 | 5 | GO:0010712 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP13A4 SLC2A9 PARK7 SLC4A1 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 CLCN6 CLCA2 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC23A1 | 1.78e-04 | 1115 | 139 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 1.81e-04 | 232 | 139 | 8 | GO:0071805 | |
| GeneOntologyBiologicalProcess | chloride transport | 2.32e-04 | 128 | 139 | 6 | GO:0006821 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | MYADM TMIGD2 PCDHAC2 CDHR5 ITGAM ITGAX CLDN12 VSIR SLC4A1 TAOK2 HHLA2 ITGBL1 KITLG DLG4 IL6 NOTCH1 PLXNB3 CRB2 | 3.38e-04 | 1077 | 139 | 18 | GO:0098609 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 3.62e-04 | 195 | 139 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | membrane hyperpolarization | 3.64e-04 | 21 | 139 | 3 | GO:0060081 | |
| GeneOntologyBiologicalProcess | retinal cone cell differentiation | 4.20e-04 | 22 | 139 | 3 | GO:0042670 | |
| GeneOntologyBiologicalProcess | import into nucleus | 4.34e-04 | 201 | 139 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | serotonergic neuron axon guidance | 4.45e-04 | 5 | 139 | 2 | GO:0036515 | |
| GeneOntologyBiologicalProcess | action potential initiation | 4.45e-04 | 5 | 139 | 2 | GO:0099610 | |
| GeneOntologyBiologicalProcess | positive regulation of melanocyte differentiation | 4.45e-04 | 5 | 139 | 2 | GO:0045636 | |
| GeneOntologyBiologicalProcess | phototransduction | 4.48e-04 | 53 | 139 | 4 | GO:0007602 | |
| GeneOntologyBiologicalProcess | glycerolipid biosynthetic process | 4.76e-04 | 268 | 139 | 8 | GO:0045017 | |
| GeneOntologyBiologicalProcess | phospholipid biosynthetic process | 4.76e-04 | 268 | 139 | 8 | GO:0008654 | |
| GeneOntologyBiologicalProcess | negative regulation of collagen biosynthetic process | 4.81e-04 | 23 | 139 | 3 | GO:0032966 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ATP13A4 SLC2A9 PARK7 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC23A1 | 4.91e-04 | 922 | 139 | 16 | GO:0098662 |
| GeneOntologyBiologicalProcess | potassium ion transport | 5.25e-04 | 272 | 139 | 8 | GO:0006813 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 6.03e-04 | 153 | 139 | 6 | GO:0098656 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 6.13e-04 | 213 | 139 | 7 | GO:0015718 | |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 6.18e-04 | 25 | 139 | 3 | GO:0055064 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP13A4 SLC2A9 PARK7 SLC6A7 SLC9A4 SLC46A3 SLC12A1 SLC12A3 KCNQ5 KCNQ4 SLC5A6 SCN2B KCNQ1 KCNQ2 KCNQ3 SLC23A1 | 6.19e-04 | 942 | 139 | 16 | GO:0098655 |
| GeneOntologyBiologicalProcess | lipid transport | SPNS1 SLC25A21 SLCO1B3 ABCA7 SLC4A1 PITPNM1 SLC22A8 KCNQ1 SLC5A8 TMEM41B NOS2 | 6.46e-04 | 506 | 139 | 11 | GO:0006869 |
| GeneOntologyBiologicalProcess | positive regulation of guanylate cyclase activity | 6.64e-04 | 6 | 139 | 2 | GO:0031284 | |
| GeneOntologyCellularComponent | apical plasma membrane | IL10RA SLC2A9 SLC2A7 SLC43A1 CDHR5 ABCA7 VANGL2 SLC9A4 SLC12A1 SLC12A3 SLC22A8 PROM2 SLC5A6 KCNQ1 UPK3A SLC5A8 SLC14A2 SLC23A1 NOTCH1 SLC16A8 CRB2 | 1.07e-11 | 487 | 139 | 21 | GO:0016324 |
| GeneOntologyCellularComponent | apical part of cell | IL10RA SLC2A9 SLC2A7 SLC43A1 CDHR5 ABCA7 VANGL2 SLC9A4 SLC12A1 SLC12A3 SLC22A8 PROM2 SLC5A6 KCNQ1 UPK3A SLC5A8 SLC14A2 SLC23A1 NOTCH1 SLC16A8 CRB2 | 3.91e-10 | 592 | 139 | 21 | GO:0045177 |
| GeneOntologyCellularComponent | basal plasma membrane | HJV SLC2A9 SLCO1B3 SLC4A1 VANGL2 SLC9A4 SLC22A8 CLCA2 PROM2 KCNQ4 SLC5A6 KCNQ1 DLG4 SLC14A2 SLC23A1 SLC16A8 | 1.87e-09 | 354 | 139 | 16 | GO:0009925 |
| GeneOntologyCellularComponent | basal part of cell | HJV SLC2A9 SLCO1B3 SLC4A1 VANGL2 SLC9A4 SLC22A8 CLCA2 PROM2 KCNQ4 SLC5A6 KCNQ1 DLG4 SLC14A2 SLC23A1 SLC16A8 | 4.78e-09 | 378 | 139 | 16 | GO:0045178 |
| GeneOntologyCellularComponent | basolateral plasma membrane | HJV SLC2A9 SLCO1B3 SLC4A1 VANGL2 SLC9A4 SLC22A8 PROM2 SLC5A6 KCNQ1 DLG4 SLC14A2 SLC16A8 | 2.30e-07 | 320 | 139 | 13 | GO:0016323 |
| GeneOntologyCellularComponent | cell surface | HJV CCR10 ACVR1B ITGAM ITGAX ABCA7 VSIR SLC4A1 ADORA2B HHLA2 ITGBL1 ARSA SLC12A1 ADAMTS9 FCGRT PROM2 KCNQ2 KCNQ3 IL6 NOTCH1 PLXNB3 | 1.43e-05 | 1111 | 139 | 21 | GO:0009986 |
| GeneOntologyCellularComponent | voltage-gated potassium channel complex | 3.25e-05 | 91 | 139 | 6 | GO:0008076 | |
| GeneOntologyCellularComponent | potassium channel complex | 6.90e-05 | 104 | 139 | 6 | GO:0034705 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | HJV TMIGD2 ACVR1B ITGAM ITGAX ITGBL1 KCNQ5 KCNQ4 SCN2B KCNQ1 KCNQ2 KCNQ3 DLG4 IL6 CRB2 | 2.36e-04 | 785 | 139 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | ATP13A4 CDS1 DPY19L3 ZMPSTE24 RPN2 SLC43A1 CDS2 AGPAT3 GPAT3 WDR81 PITPNM1 LMAN1L ZDHHC6 GUCY2D UPK3A TMEM41B G6PC1 PIGO ILVBL NOTCH1 | 3.56e-04 | 1293 | 139 | 20 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | ATP13A4 CDS1 DPY19L3 ZMPSTE24 RPN2 SLC43A1 CDS2 AGPAT3 GPAT3 WDR81 PITPNM1 LMAN1L ZDHHC6 GUCY2D UPK3A TMEM41B G6PC1 PIGO ILVBL NOTCH1 | 3.78e-04 | 1299 | 139 | 20 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | ATP13A4 CDS1 DPY19L3 ZMPSTE24 RPN2 SLC43A1 CDS2 AGPAT3 GPAT3 WDR81 PITPNM1 LMAN1L ZDHHC6 GUCY2D UPK3A TMEM41B G6PC1 PIGO ILVBL NOTCH1 | 4.96e-04 | 1327 | 139 | 20 | GO:0042175 |
| GeneOntologyCellularComponent | receptor complex | HJV TMIGD2 ACVR1B GPRC5A ITGAM ITGAX TAOK2 ITGBL1 DLG4 IL6 NOTCH1 PLXNB3 | 5.13e-04 | 581 | 139 | 12 | GO:0043235 |
| GeneOntologyCellularComponent | cation channel complex | 1.01e-03 | 235 | 139 | 7 | GO:0034703 | |
| GeneOntologyCellularComponent | integrin complex | 1.24e-03 | 32 | 139 | 3 | GO:0008305 | |
| GeneOntologyCellularComponent | nonhomologous end joining complex | 1.53e-03 | 9 | 139 | 2 | GO:0070419 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 2.40e-03 | 350 | 139 | 8 | GO:0098802 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 2.20e-11 | 5 | 140 | 5 | IPR013821 | |
| Domain | K_chnl_volt-dep_KCNQ | 2.20e-11 | 5 | 140 | 5 | IPR003937 | |
| Domain | KCNQ_channel | 2.20e-11 | 5 | 140 | 5 | PF03520 | |
| Domain | MFS_dom | SPNS1 SLC16A13 SLC2A9 SLC2A7 SLC43A1 SLC22A15 SLCO1B3 SLC46A3 SLC22A8 SLC16A8 | 6.70e-08 | 134 | 140 | 10 | IPR020846 |
| Domain | MFS | SPNS1 SLC16A13 SLC2A9 SLC2A7 SLC22A15 SLCO1B3 SLC46A3 SLC22A8 SLC16A8 | 1.20e-07 | 108 | 140 | 9 | PS50850 |
| Domain | VG_K_chnl | 4.42e-06 | 33 | 140 | 5 | IPR028325 | |
| Domain | MFS_1 | 2.44e-05 | 77 | 140 | 6 | PF07690 | |
| Domain | MFS | 2.44e-05 | 77 | 140 | 6 | IPR011701 | |
| Domain | PC_trans | 5.58e-05 | 2 | 140 | 2 | IPR000374 | |
| Domain | KCNQC3-Ank-G_bd | 5.58e-05 | 2 | 140 | 2 | PF11956 | |
| Domain | VANGL | 5.58e-05 | 2 | 140 | 2 | IPR009539 | |
| Domain | PC_Trfase_euk | 5.58e-05 | 2 | 140 | 2 | IPR016720 | |
| Domain | CDS | 5.58e-05 | 2 | 140 | 2 | PS01315 | |
| Domain | K_chnl_volt-dep_KCNQ2 | 5.58e-05 | 2 | 140 | 2 | IPR003947 | |
| Domain | Ankyrin-G_BS | 5.58e-05 | 2 | 140 | 2 | IPR020969 | |
| Domain | Strabismus | 5.58e-05 | 2 | 140 | 2 | PF06638 | |
| Domain | MFS_sugar_transport-like | 1.48e-04 | 36 | 140 | 4 | IPR005828 | |
| Domain | Sugar_tr | 1.48e-04 | 36 | 140 | 4 | PF00083 | |
| Domain | Xan_ur_permease | 1.67e-04 | 3 | 140 | 2 | PF00860 | |
| Domain | AA_permease_N | 1.67e-04 | 3 | 140 | 2 | IPR013612 | |
| Domain | Xant/urac/vitC | 1.67e-04 | 3 | 140 | 2 | IPR006043 | |
| Domain | AA_permease_N | 1.67e-04 | 3 | 140 | 2 | PF08403 | |
| Domain | AA-permease/SLC12A_dom | 5.72e-04 | 22 | 140 | 3 | IPR004841 | |
| Domain | AA_permease | 5.72e-04 | 22 | 140 | 3 | PF00324 | |
| Domain | GroES-like | 7.43e-04 | 24 | 140 | 3 | IPR011032 | |
| Domain | SLC12A_fam | 1.14e-03 | 7 | 140 | 2 | IPR004842 | |
| Domain | SLC12_C | 1.52e-03 | 8 | 140 | 2 | IPR018491 | |
| Domain | SLC12 | 1.52e-03 | 8 | 140 | 2 | PF03522 | |
| Domain | Ion_trans_dom | 1.68e-03 | 114 | 140 | 5 | IPR005821 | |
| Domain | Ion_trans | 1.68e-03 | 114 | 140 | 5 | PF00520 | |
| Domain | Sugar_transporter_CS | 1.74e-03 | 32 | 140 | 3 | IPR005829 | |
| Domain | BEACH | 1.94e-03 | 9 | 140 | 2 | PS50197 | |
| Domain | Beach | 1.94e-03 | 9 | 140 | 2 | PF02138 | |
| Domain | - | 1.94e-03 | 9 | 140 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.94e-03 | 9 | 140 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.94e-03 | 9 | 140 | 2 | IPR000409 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A9 SLC2A7 SLC43A1 SLC22A15 SLCO1B3 SLC4A1 SLC6A7 SLC9A4 SLC12A1 SLC12A3 SLC22A8 SLC5A6 SLC5A8 SLC14A2 SLC16A8 | 1.36e-10 | 238 | 101 | 15 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC2A9 SLC2A7 SLC43A1 SLC22A15 SLCO1B3 SLC4A1 SLC6A7 SLC9A4 SLC12A1 SLC12A3 SLC22A8 SLC5A6 SLC5A8 SLC14A2 SLC16A8 | 2.57e-10 | 249 | 101 | 15 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP13A4 SLC2A9 SLC2A7 SLC43A1 SLC22A15 SLCO1B3 ABCA7 SLC4A1 SLC6A7 SLC9A4 SLC12A1 SLC12A3 SLC22A8 CLCN6 CLCA2 SLC5A6 SLC5A8 SLC14A2 SLC16A8 | 3.02e-07 | 681 | 101 | 19 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP13A4 SLC2A9 SLC2A7 SLC43A1 SLC22A15 SLCO1B3 ABCA7 SLC4A1 SLC6A7 SLC9A4 SLC12A1 SLC12A3 SLC22A8 CLCN6 CLCA2 SLC5A6 SLC5A8 SLC14A2 SLC16A8 | 9.83e-07 | 736 | 101 | 19 | M27287 |
| Pathway | BIOCARTA_RACC_PATHWAY | 3.19e-06 | 15 | 101 | 4 | M22002 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 6.82e-06 | 99 | 101 | 7 | M27474 | |
| Pathway | REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS | 1.33e-05 | 43 | 101 | 5 | M1056 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.24e-04 | 108 | 101 | 6 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 1.30e-04 | 109 | 101 | 6 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 2.11e-04 | 76 | 101 | 5 | MM15072 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 2.79e-04 | 177 | 101 | 7 | M27476 | |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | 3.37e-04 | 84 | 101 | 5 | M27334 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 5.01e-04 | 5 | 101 | 2 | M26962 | |
| Pathway | REACTOME_SYNTHESIS_OF_PI | 5.01e-04 | 5 | 101 | 2 | MM14587 | |
| Pubmed | The contribution of Kv7 channels to pregnant mouse and human myometrial contractility. | 9.84e-13 | 5 | 140 | 5 | 20132415 | |
| Pubmed | A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly. | 2.52e-10 | 4 | 140 | 4 | 12524525 | |
| Pubmed | 2.52e-10 | 4 | 140 | 4 | 10713961 | ||
| Pubmed | Dual phosphorylations underlie modulation of unitary KCNQ K(+) channels by Src tyrosine kinase. | 1.25e-09 | 5 | 140 | 4 | 15304482 | |
| Pubmed | 3.75e-09 | 6 | 140 | 4 | 21730298 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 18786918 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 12890507 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 17519950 | ||
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 26969140 | ||
| Pubmed | MYADM ATP13A4 TMIGD2 SLC22A15 AGPAT3 GPAT3 CDHR5 COMTD1 VSIR TAOK2 LMAN1L TMUB1 TMEM161A PROM2 SCN2B KCNQ2 GKN1 PIGO | 9.78e-08 | 985 | 140 | 18 | 12975309 | |
| Pubmed | Neuronal nitric oxide synthase is necessary for elimination of Giardia lamblia infections in mice. | 2.55e-07 | 4 | 140 | 3 | 16365445 | |
| Pubmed | 5.78e-07 | 40 | 140 | 5 | 16382104 | ||
| Pubmed | 1.27e-06 | 6 | 140 | 3 | 12032157 | ||
| Pubmed | 1.95e-06 | 143 | 140 | 7 | 20424473 | ||
| Pubmed | Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. | 3.52e-06 | 8 | 140 | 3 | 18097035 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | SPNS1 DPY19L3 ZMPSTE24 AGPAT3 PCDHAC2 ACVR1B CLDN12 VSIR TMUB1 CNNM3 ZDHHC6 TTI1 PRKDC UBE3C PIGO NOTCH1 | 6.25e-06 | 1061 | 140 | 16 | 33845483 |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MYADM DPY19L3 ZMPSTE24 RPN2 GPRC5A ABCA7 TMEM106B CNNM3 TMEM161A ARSA ZDHHC6 TMEM245 SLC5A6 TTI1 TMEM41B PIGO NOTCH1 | 7.23e-06 | 1201 | 140 | 17 | 35696571 |
| Pubmed | 1.19e-05 | 73 | 140 | 5 | 23464991 | ||
| Pubmed | Notch signaling promotes nephrogenesis by downregulating Six2. | 1.37e-05 | 12 | 140 | 3 | 27633993 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 1.50e-05 | 37 | 140 | 4 | 25798587 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ZMPSTE24 PARK7 CDHR5 GPRC5A TSPAN1 SLC4A1 SLC46A3 SLC12A1 SLC12A3 SLC22A8 PROM2 UPK3A SLC5A8 SLC23A1 CRB2 | 1.59e-05 | 1016 | 140 | 15 | 19056867 |
| Pubmed | Association of ITGAX and ITGAM gene polymorphisms with susceptibility to IgA nephropathy. | 1.61e-05 | 2 | 140 | 2 | 31227791 | |
| Pubmed | KCNQ channels show conserved ethanol block and function in ethanol behaviour. | 1.61e-05 | 2 | 140 | 2 | 23209695 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 10684873 | ||
| Pubmed | A novel hypomorphic Looptail allele at the planar cell polarity Vangl2 gene. | 1.61e-05 | 2 | 140 | 2 | 21404367 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21394214 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15769552 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16721610 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 8573344 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25445275 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29207018 | ||
| Pubmed | CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms. | 1.61e-05 | 2 | 140 | 2 | 31548309 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15608631 | ||
| Pubmed | Benign neonatal sleep myoclonus: an autosomal dominant form not allelic to KCNQ2 or KCNQ3. | 1.61e-05 | 2 | 140 | 2 | 22447848 | |
| Pubmed | Remodeling of Kv7.1 and Kv7.5 Expression in Vascular Tumors. | 1.61e-05 | 2 | 140 | 2 | 32825637 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16319223 | ||
| Pubmed | Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channels causes epilepsy. | 1.61e-05 | 2 | 140 | 2 | 9872318 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23002961 | ||
| Pubmed | Expression of the c-kit ligand and interleukin 6 genes in mouse bone marrow stromal cell lines. | 1.61e-05 | 2 | 140 | 2 | 7524893 | |
| Pubmed | Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells. | 1.61e-05 | 2 | 140 | 2 | 7561687 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15887117 | ||
| Pubmed | KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes. | 1.61e-05 | 2 | 140 | 2 | 18625963 | |
| Pubmed | Vestibular role of KCNQ4 and KCNQ5 K+ channels revealed by mouse models. | 1.61e-05 | 2 | 140 | 2 | 23408425 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 29474891 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23567299 | ||
| Pubmed | Loss of membrane targeting of Vangl proteins causes neural tube defects. | 1.61e-05 | 2 | 140 | 2 | 21142127 | |
| Pubmed | Contribution of KCNQ2 and KCNQ3 to the medium and slow afterhyperpolarization currents. | 1.61e-05 | 2 | 140 | 2 | 19060215 | |
| Pubmed | DNA methylation and expression of KCNQ3 in bipolar disorder. | 1.61e-05 | 2 | 140 | 2 | 25041603 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30548441 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 37562584 | ||
| Pubmed | Scn2b, a voltage-gated sodium channel beta2 gene on mouse chromosome 9. | 1.61e-05 | 2 | 140 | 2 | 8661062 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28183849 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25740509 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22882618 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 35175496 | ||
| Pubmed | Isolation and characterization of murine Cds (CDP-diacylglycerol synthase) 1 and 2. | 1.61e-05 | 2 | 140 | 2 | 16023307 | |
| Pubmed | PAR-2 is involved in melanogenesis by mediating stem cell factor production in keratinocytes. | 1.61e-05 | 2 | 140 | 2 | 26909822 | |
| Pubmed | KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3. | 1.61e-05 | 2 | 140 | 2 | 35320039 | |
| Pubmed | Endothelial interleukin-6 defines the tumorigenic potential of primary human cancer stem cells. | 1.61e-05 | 2 | 140 | 2 | 25078284 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 14534157 | ||
| Pubmed | Disruption of the epilepsy KCNQ2 gene results in neural hyperexcitability. | 1.61e-05 | 2 | 140 | 2 | 10854243 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 27607834 | ||
| Pubmed | Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy. | 1.61e-05 | 2 | 140 | 2 | 14597766 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22204707 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 36394557 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25068569 | ||
| Pubmed | Direct regulation of interleukin-6 expression by Notch signaling in macrophages. | 1.61e-05 | 2 | 140 | 2 | 21983868 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32580997 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22488247 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18483067 | ||
| Pubmed | Isolation and chromosomal localization of two human CDP-diacylglycerol synthase (CDS) genes. | 1.61e-05 | 2 | 140 | 2 | 9806839 | |
| Pubmed | CDP-diacylglycerol synthases regulate the growth of lipid droplets and adipocyte development. | 1.61e-05 | 2 | 140 | 2 | 26946540 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 31050560 | ||
| Pubmed | Rapid chemically induced changes of PtdIns(4,5)P2 gate KCNQ ion channels. | 1.61e-05 | 2 | 140 | 2 | 16990515 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19797068 | ||
| Pubmed | Subcutaneous delivery of an antibody against SARS-CoV-2 from a supramolecular hydrogel depot. | 1.61e-05 | 2 | 140 | 2 | 36723072 | |
| Pubmed | The Kv7.2/Kv7.3 heterotetramer assembles with a random subunit arrangement. | 1.61e-05 | 2 | 140 | 2 | 22334706 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 37968800 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12832524 | ||
| Pubmed | Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis. | 1.61e-05 | 2 | 140 | 2 | 15339938 | |
| Pubmed | A2B adenosine receptor-mediated induction of IL-6 promotes CKD. | 1.61e-05 | 2 | 140 | 2 | 21511827 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28758875 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 10479678 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 35187955 | ||
| Pubmed | Molecular characterisation of endogenous Vangl2/Vangl1 heteromeric protein complexes. | 1.61e-05 | 2 | 140 | 2 | 23029439 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19453707 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23784006 | ||
| Pubmed | Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents. | 1.61e-05 | 2 | 140 | 2 | 18536747 | |
| Pubmed | Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells. | 1.61e-05 | 2 | 140 | 2 | 11159685 | |
| Pubmed | Effects of retinoic acid on the expressions of Vangl1 and vangl2 in mouse fetuses. | 1.61e-05 | 2 | 140 | 2 | 19012162 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 36108571 | ||
| Pubmed | Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. | 1.61e-05 | 2 | 140 | 2 | 10908292 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34283878 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18453602 | ||
| Pubmed | Distinct properties of the two isoforms of CDP-diacylglycerol synthase. | 1.61e-05 | 2 | 140 | 2 | 25375833 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12640002 | ||
| Pubmed | KCNQ Potassium Channels Modulate Sensitivity of Skin Down-hair (D-hair) Mechanoreceptors. | 1.61e-05 | 2 | 140 | 2 | 26733196 | |
| Pubmed | Functional assembly of Kv7.1/Kv7.5 channels with emerging properties on vascular muscle physiology. | 1.61e-05 | 2 | 140 | 2 | 24855057 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 26627826 | ||
| Pubmed | Course of Brugia malayi infection in C57BL/6J NOS2 +/+ and -/- mice. | 1.61e-05 | 2 | 140 | 2 | 11426950 | |
| Interaction | YIPF3 interactions | CDS1 SLC43A1 CDS2 AGPAT3 LMBR1 F2RL1 TMEM245 SLC5A6 CMKLR1 S1PR4 | 6.27e-07 | 186 | 138 | 10 | int:YIPF3 |
| Interaction | MTX3 interactions | 8.93e-07 | 76 | 138 | 7 | int:MTX3 | |
| Interaction | CACNG4 interactions | 3.09e-06 | 59 | 138 | 6 | int:CACNG4 | |
| Interaction | TSPAN17 interactions | 9.97e-06 | 72 | 138 | 6 | int:TSPAN17 | |
| Interaction | THADA interactions | 1.52e-05 | 116 | 138 | 7 | int:THADA | |
| Interaction | SIGMAR1 interactions | 1.61e-05 | 117 | 138 | 7 | int:SIGMAR1 | |
| Interaction | KCNQ3 interactions | 2.01e-05 | 24 | 138 | 4 | int:KCNQ3 | |
| Interaction | PTDSS2 interactions | 3.37e-05 | 89 | 138 | 6 | int:PTDSS2 | |
| Interaction | KCNS1 interactions | 3.64e-05 | 10 | 138 | 3 | int:KCNS1 | |
| Interaction | TVP23C interactions | 4.04e-05 | 56 | 138 | 5 | int:TVP23C | |
| Interaction | GK interactions | 4.32e-05 | 93 | 138 | 6 | int:GK | |
| Interaction | FPR2 interactions | 4.66e-05 | 138 | 138 | 7 | int:FPR2 | |
| Interaction | SLC6A8 interactions | 6.38e-05 | 145 | 138 | 7 | int:SLC6A8 | |
| Interaction | MT-CO1 interactions | 6.62e-05 | 62 | 138 | 5 | int:MT-CO1 | |
| Interaction | TTI1 interactions | 6.87e-05 | 101 | 138 | 6 | int:TTI1 | |
| Interaction | GPR182 interactions | SPNS1 CDS1 RPN2 CDS2 GPAT3 F2RL1 TMEM161A RPAP1 TTI1 PRKDC UBE3C PIGO | 7.09e-05 | 455 | 138 | 12 | int:GPR182 |
| Interaction | INTS2 interactions | 7.26e-05 | 102 | 138 | 6 | int:INTS2 | |
| Interaction | KIR2DL2 interactions | 8.54e-05 | 13 | 138 | 3 | int:KIR2DL2 | |
| Interaction | IGDCC4 interactions | 9.35e-05 | 35 | 138 | 4 | int:IGDCC4 | |
| Interaction | ZW10 interactions | 9.70e-05 | 155 | 138 | 7 | int:ZW10 | |
| Interaction | OPALIN interactions | 9.80e-05 | 209 | 138 | 8 | int:OPALIN | |
| Interaction | POMK interactions | 1.07e-04 | 271 | 138 | 9 | int:POMK | |
| Interaction | IPO11 interactions | 1.14e-04 | 159 | 138 | 7 | int:IPO11 | |
| Interaction | PBXIP1 interactions | 1.23e-04 | 216 | 138 | 8 | int:PBXIP1 | |
| Interaction | SGCA interactions | 1.28e-04 | 113 | 138 | 6 | int:SGCA | |
| Interaction | XPO5 interactions | 1.73e-04 | 227 | 138 | 8 | int:XPO5 | |
| Interaction | SLC22A9 interactions | 1.78e-04 | 120 | 138 | 6 | int:SLC22A9 | |
| Interaction | TTYH1 interactions | 2.28e-04 | 300 | 138 | 9 | int:TTYH1 | |
| Interaction | TMUB2 interactions | 2.31e-04 | 44 | 138 | 4 | int:TMUB2 | |
| Interaction | TNPO3 interactions | 2.32e-04 | 237 | 138 | 8 | int:TNPO3 | |
| GeneFamily | Solute carriers | SLC25A21 SLC16A13 SLC2A9 SLC2A7 SLC43A1 SLC22A15 SLCO1B3 SLC4A1 SLC6A7 SLC7A4 SLC9A4 SLC46A3 SLC12A1 SLC12A3 SLC22A8 SLC5A6 SLC5A8 SLC14A2 SLC23A1 SLC16A8 SLC23A3 | 2.16e-15 | 395 | 98 | 21 | 752 |
| GeneFamily | Potassium voltage-gated channels | 2.39e-06 | 40 | 98 | 5 | 274 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.02e-03 | 9 | 98 | 2 | 1230 | |
| GeneFamily | 1-acylglycerol-3-phosphate O-acyltransferases | 1.55e-03 | 11 | 98 | 2 | 46 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | MYADM SPNS1 SLC16A13 DPY19L3 CDS2 ACVR1B GPRC5A CLDN12 ADORA2B TMEM161A CLCN6 TMEM245 SLC5A6 TMEM41B PIGO ILVBL | 7.08e-07 | 681 | 139 | 16 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | MYADM SPNS1 SLC16A13 DPY19L3 CDS2 ACVR1B GPRC5A CLDN12 ADORA2B TMEM161A CLCN6 TMEM245 SLC5A6 TMEM41B PIGO ILVBL | 1.07e-06 | 703 | 139 | 16 | MM1055 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | IL10RA FKBP15 MYADM SPNS1 HK3 SLC2A9 PAXX ACVR1B ITGAX FAAP100 CASZ1 VSIR PITPNM1 CNNM3 CLCN6 FCGRT NOTCH1 | 6.42e-06 | 905 | 139 | 17 | M40865 |
| Coexpression | DESCARTES_FETAL_SPLEEN_MYELOID_CELLS | 6.88e-06 | 132 | 139 | 7 | M40289 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 1.07e-05 | 197 | 139 | 8 | M5347 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN | 1.20e-05 | 200 | 139 | 8 | M4667 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | 1.20e-05 | 200 | 139 | 8 | M6208 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.20e-05 | 200 | 139 | 8 | M9181 | |
| Coexpression | GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 9.29e-05 | 198 | 139 | 7 | M5344 | |
| Coexpression | GSE11924_TH1_VS_TH17_CD4_TCELL_DN | 9.59e-05 | 199 | 139 | 7 | M3163 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP | 9.89e-05 | 200 | 139 | 7 | M3957 | |
| Coexpression | GSE5960_TH1_VS_ANERGIC_TH1_DN | 9.89e-05 | 200 | 139 | 7 | M5638 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | IL10RA MYADM CDS1 HK3 SLC43A1 GPAT3 COMTD1 F2RL1 ITGAX WDFY4 VSIR PITPNM1 ADPRH ITGBL1 ZDHHC6 TMEM245 MS4A6A PLXNB3 | 1.04e-04 | 1242 | 139 | 18 | M1920 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_k-means-cluster#3_top-relative-expression-ranked_100 | 2.67e-05 | 27 | 138 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_100_k3 | |
| CoexpressionAtlas | kidney | SLC2A9 GPAT3 CDHR5 SLC12A1 SLC12A3 SLC22A8 SLC14A2 G6PC1 SLC23A1 SLC23A3 | 5.12e-05 | 323 | 138 | 10 | kidney |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_1000 | ATP13A4 CDS1 SLC16A13 GPAT3 CDHR5 COMTD1 PITPNM1 TMEM161A SLC22A8 FCGRT SLC5A6 KCNQ2 SLC5A8 SLC23A1 PIGO SLC23A3 | 5.15e-05 | 784 | 138 | 16 | gudmap_developingKidney_e15.5_early proxim tubul_1000 |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | 1.15e-08 | 194 | 140 | 9 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.50e-08 | 200 | 140 | 9 | 62e9ca7cf4f49fc8957740acee41a1e530f10541 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Neutrophil|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.32e-07 | 185 | 140 | 8 | 655fb705d7a029844ecb4f6a53e948e37ee81006 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Epithelial-duct_epithelial_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-07 | 190 | 140 | 8 | 5b3f773380aef4773b70f0dbd74992d28e6586c6 | |
| ToppCell | Control-Myeloid-Monocyte-derived_macrophages|Control / group, cell type (main and fine annotations) | 1.83e-07 | 193 | 140 | 8 | a6b3bd01e585e2e3fbe9bf693a2e385773123f8e | |
| ToppCell | Adult-Immune-monocyte-D122|Adult / Lineage, Cell type, age group and donor | 2.05e-07 | 196 | 140 | 8 | 16b0acb6157534938ca83d4e909471e33a7d3c52 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 2.05e-07 | 196 | 140 | 8 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.05e-07 | 196 | 140 | 8 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.14e-07 | 197 | 140 | 8 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.22e-07 | 198 | 140 | 8 | 6a4161680b46b2c12353a693c403b5a4bb3da03f | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-07 | 200 | 140 | 8 | ad52b38df5c71f28829b04cd0e6b97f0f9f7610a | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic-monocyte-CD14_monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.40e-07 | 200 | 140 | 8 | 07197f95282ee607db17b92fea1376051e65fc50 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.40e-07 | 142 | 140 | 7 | ae495c8dd733f0fde66bddc281606543f21c0d4b | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.62e-07 | 160 | 140 | 7 | 7f1b58641ba149d20420fafad34ba78a65a2c701 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 169 | 140 | 7 | 735655e75511c5c41aca667909e8bb52a0ad7fc6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-06 | 172 | 140 | 7 | cf46810dd1072b6f2171e5d9530351ddc79a055b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-06 | 186 | 140 | 7 | e41f14aee8cfbf76b8d0d4695a6170e2cd92aec8 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-pDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.08e-06 | 186 | 140 | 7 | d23c3318937492d7d665bec14253124c49181b5a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-06 | 186 | 140 | 7 | b3633cd4e360c5b45060c50b4f606d483e03a89a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid-Micro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.08e-06 | 186 | 140 | 7 | 9dd31dc9af1704f35c74de726a6c27fa21e9a014 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Endothelial_Myeloid|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-06 | 187 | 140 | 7 | 23a42c172d5cc36cb8793c0bc2ce357c6c8e5d39 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 187 | 140 | 7 | 22fd1959879705a8c1128faa9de66696c4e0b7e3 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 187 | 140 | 7 | 5fae538de481367cf6d9a2d52190d77b99f6922c | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 187 | 140 | 7 | 0526c0a818cf28fd5b6ff65fe260e3c3a4a98a2a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-06 | 188 | 140 | 7 | 26c0a94951236a5d17a169920b0a8a9d0dd7d0ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro-Microglia-Micro_L1-6_C1QC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-06 | 188 | 140 | 7 | af300574c4e95505f56bf716bcee1e4777944e8e | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-06 | 188 | 140 | 7 | c65fb9a3c910dd6166853f4f3a2f2c2411ccf03b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Micro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-06 | 188 | 140 | 7 | e169e9bb85892e52880ee949d0f691d0ea0c8dc9 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-06 | 188 | 140 | 7 | 1f820cb19eb0e15f0eb69d07e457072bbdad8ecb | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.40e-06 | 190 | 140 | 7 | 1687e133a88c3d036a33a4f8aeefe320a4f02c39 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.40e-06 | 190 | 140 | 7 | 3cfc2646ba25b4bd8bb443cc1f46e18a270a1969 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-06 | 190 | 140 | 7 | 4836ea19308d2a96694f12ab0653b7ce7b101d2f | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.40e-06 | 190 | 140 | 7 | 5e0e4a48159ec05ba1b599752b769a7b4da08588 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 190 | 140 | 7 | d4910c37045a8b8bb53b37625263bc0a47b6e3f8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-06 | 191 | 140 | 7 | c72e62cf5b45c04ee5e7719db31f917c4f76b1e4 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 2.66e-06 | 193 | 140 | 7 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.66e-06 | 193 | 140 | 7 | f597fefc54327a1ad136e2f66b6e81cc5c761eb7 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 2.75e-06 | 194 | 140 | 7 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 194 | 140 | 7 | 0866ab6792cee274a71991d5c37a37f574ff446e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-06 | 194 | 140 | 7 | badefcec2af86cbcd97305f4843e84db0f3ebc66 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_dendritic_(11)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.85e-06 | 195 | 140 | 7 | 4387e27d2288fb46a9ed110464542a4aea402358 | |
| ToppCell | COVID-19-Myeloid-Monocyte-derived_macrophages|COVID-19 / group, cell type (main and fine annotations) | 2.85e-06 | 195 | 140 | 7 | c172c5599379c29123340621a36bfb1fc90c2115 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 2.85e-06 | 195 | 140 | 7 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.85e-06 | 195 | 140 | 7 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | Adult-Immune-monocyte|Adult / Lineage, Cell type, age group and donor | 2.95e-06 | 196 | 140 | 7 | 3ef193c5180de3137daf886492e74fc574bc9767 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_Macrophage|Airway / Age, Tissue, Lineage and Cell class | 2.95e-06 | 196 | 140 | 7 | f73573b5d9c735f2a2c718472b7d12b10f2a3718 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-06 | 196 | 140 | 7 | 4370473693d2dd4a8c451a4c477eb79baa33ae12 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.95e-06 | 196 | 140 | 7 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.05e-06 | 197 | 140 | 7 | b597c292fc1cb381a4325fed15a32966c38def28 | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.05e-06 | 197 | 140 | 7 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.05e-06 | 197 | 140 | 7 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.05e-06 | 197 | 140 | 7 | 3896729740d151f0eb845f1961c7b969bfbdd28d | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.05e-06 | 197 | 140 | 7 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | Healthy/Control-cDC|World / Disease group and Cell class | 3.05e-06 | 197 | 140 | 7 | 4497d4073f4d3e74de907325fba9eb4af5766bf4 | |
| ToppCell | Healthy/Control-cDC|Healthy/Control / Disease group and Cell class | 3.05e-06 | 197 | 140 | 7 | 926423aae9fcf654f84b0f7621103a6a22d3aced | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-06 | 197 | 140 | 7 | c34d0d11c5c6154988b41e00aea169090cb09785 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-06 | 198 | 140 | 7 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.15e-06 | 198 | 140 | 7 | 1d242fbe4ae3628103f6b6f910a7641bb1b75266 | |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | 3.15e-06 | 198 | 140 | 7 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 3.15e-06 | 198 | 140 | 7 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.26e-06 | 199 | 140 | 7 | cd93e8947bcf3c2d7e6d5bfd70300145fba15f74 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-06 | 199 | 140 | 7 | 9545ac59c8d75f5747dff86cb511a149dc103b31 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-06 | 199 | 140 | 7 | aa30a57c0907d012942e7babdbff6ea4d01d7798 | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_monocytic-monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.26e-06 | 199 | 140 | 7 | 7e5a56bb2ac441a8fa4ad0b928f9c0c82d128190 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-06 | 199 | 140 | 7 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-06 | 199 | 140 | 7 | b818d46a39c8782188d82dc8931b8eec9d549dd1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.26e-06 | 199 | 140 | 7 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-06 | 200 | 140 | 7 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_monocytic-monocyte-CD14_monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.37e-06 | 200 | 140 | 7 | 4984d27b3768be3b8fca3391cd2b7ab1749e2913 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.37e-06 | 200 | 140 | 7 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-06 | 200 | 140 | 7 | 26df6ac63710655604888c3be6509b6c4befc0be | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-06 | 200 | 140 | 7 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-06 | 200 | 140 | 7 | 5432bdf495431cd26f6e4cd585100f3652588913 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.37e-06 | 200 | 140 | 7 | 8872d5fa101d413fb43b4231d476878678543035 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.37e-06 | 200 | 140 | 7 | 07819a90ac347883b78d0bb3cd8c5eb0d66e1e22 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.91e-06 | 146 | 140 | 6 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-06 | 152 | 140 | 6 | c21e2152b0130485659051d8fb7fb4589d1ec997 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 9.04e-06 | 153 | 140 | 6 | 5424494ea1f09542799045a875cc3eac13de5079 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.09e-05 | 158 | 140 | 6 | 50df52d64d07178975563abd98ce4fddb9f2f7ef | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.17e-05 | 160 | 140 | 6 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | facs-Marrow-B-cells-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-05 | 164 | 140 | 6 | 18eeda51e69722992c3a7f699be293535a90868b | |
| ToppCell | NS-critical-d_07-13-Myeloid-pDC|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.39e-05 | 165 | 140 | 6 | 17d5c4a111d9b5400780bc5e7b93ce2f5d69ceb7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-05 | 166 | 140 | 6 | 83d0c26ccee605df6b04bbca31661bf4ff4f22ba | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 166 | 140 | 6 | 35db3022c33d6f8bb6587d9eec89a7cccb70271a | |
| ToppCell | Monocytes-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.54e-05 | 168 | 140 | 6 | 9ea3c682ce4e98f1a3303f99b4c63c2cf8863abc | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-05 | 168 | 140 | 6 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 172 | 140 | 6 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-05 | 175 | 140 | 6 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 177 | 140 | 6 | cdad5a2f672a7f07c05669bfcaf1ec74defd3de7 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.07e-05 | 177 | 140 | 6 | 991ae76bb615392d84aeb89886148fa42c1c649c | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.14e-05 | 106 | 140 | 5 | d8868c10785e52a1c22c91e1d0e208f2070393bb | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 179 | 140 | 6 | ce95b601bf17ae8167d382a105384b9e65e9407f | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-05 | 180 | 140 | 6 | cd743f81838ba210e5bb63fe0870918d7d2b0112 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-05 | 180 | 140 | 6 | 97241f62ee133dcb0d4855ffda5dd1349de9f7b2 | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.27e-05 | 180 | 140 | 6 | 41896546cd1cc458e08c0d4e19aa4860e5d4fcd6 | |
| ToppCell | ILEUM-non-inflamed-(3)_DC1|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.34e-05 | 181 | 140 | 6 | c9f53720249c8569598cc859e43e35c5f3f8475a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.34e-05 | 181 | 140 | 6 | 090e89b506d945e123e647d08947e9649a65ce7c | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 182 | 140 | 6 | b8be66a867ea1bbae0820b26dbd55b68611f5ad5 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-05 | 182 | 140 | 6 | cb488f9a9b200e2557335ccf22535cd247512cdc | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.45e-05 | 109 | 140 | 5 | 4e4a884b8979f4ff8b232c1581ea78884dda29ed | |
| Computational | Peptide and AA transporters. | 1.23e-05 | 18 | 89 | 4 | MODULE_368 | |
| Drug | N-(1-(3-morpholin-4-ylphenyl)ethyl)-3-phenylacrylamide | 4.71e-11 | 6 | 139 | 5 | ctd:C476437 | |
| Drug | benzanilide | 3.54e-10 | 16 | 139 | 6 | CID000007168 | |
| Drug | valrocemide | 4.35e-10 | 8 | 139 | 5 | CID006918293 | |
| Drug | isovaleramide | 4.35e-10 | 8 | 139 | 5 | CID000010930 | |
| Drug | eslicarbazepine acetate | 4.35e-10 | 8 | 139 | 5 | CID000179344 | |
| Drug | Quinazolinones | 6.62e-09 | 5 | 139 | 4 | ctd:D052999 | |
| Drug | BMS-204352 | 9.76e-09 | 13 | 139 | 5 | CID000214350 | |
| Drug | carisbamate | 3.26e-08 | 16 | 139 | 5 | CID006918474 | |
| Drug | XE991 | 4.49e-08 | 33 | 139 | 6 | CID000656732 | |
| Drug | glibenclamide | ZMPSTE24 F2RL1 ABCA7 ADORA2B ADO KCNQ5 CLCN6 CLCA2 KCNQ4 KCNQ1 KCNQ2 KCNQ3 G6PC1 NOS2 | 9.71e-08 | 382 | 139 | 14 | CID000003488 |
| Drug | Thallium | 1.91e-07 | 22 | 139 | 5 | ctd:D013793 | |
| Drug | ezogabine | 2.23e-07 | 3 | 139 | 3 | ctd:C101866 | |
| Drug | linopirdine | 2.23e-07 | 3 | 139 | 3 | ctd:C061017 | |
| Drug | (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide | 2.23e-07 | 3 | 139 | 3 | ctd:C576869 | |
| Drug | CCD 1042 | 3.80e-07 | 25 | 139 | 5 | CID000038022 | |
| Drug | rufinamide | 8.33e-07 | 29 | 139 | 5 | CID000129228 | |
| Drug | 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone | 8.87e-07 | 4 | 139 | 3 | ctd:C112297 | |
| Drug | E 4031 | 9.43e-07 | 54 | 139 | 6 | CID000003184 | |
| Drug | niflumic acid | 1.02e-06 | 125 | 139 | 8 | CID000004488 | |
| Drug | valnoctamide | 1.18e-06 | 31 | 139 | 5 | CID000020140 | |
| Drug | Vanadium | 1.21e-06 | 173 | 139 | 9 | ctd:D014639 | |
| Drug | BE-4-4-4 | 2.21e-06 | 5 | 139 | 3 | CID000060702 | |
| Drug | sodium | HJV SPNS1 SLC16A13 SLC2A9 SLC2A7 SLCO1B3 SLC4A1 SLC6A7 SLC7A4 SLC12A1 SLC12A3 SLC22A8 SLC5A6 SCN2B KCNQ1 SLC5A8 SLC14A2 NOS2 SLC23A1 | 4.88e-06 | 944 | 139 | 19 | CID000000923 |
| Drug | sotalol | 5.65e-06 | 73 | 139 | 6 | CID000005253 | |
| Drug | linopirdine | 6.30e-06 | 43 | 139 | 5 | CID000003932 | |
| Drug | LY 300164 | 6.30e-06 | 43 | 139 | 5 | CID000126756 | |
| Drug | 2-deoxy-D-glucose 6-phosphate | 7.34e-06 | 21 | 139 | 4 | CID000440992 | |
| Drug | Anti-Inflammatory Agents | 7.66e-06 | 7 | 139 | 3 | ctd:D000893 | |
| Drug | vinylidene chloride | CDS1 SLC22A15 AGPAT3 PHTF2 CDHR5 ITGAM ITGAX VSIR TSPAN1 SLC46A3 ARSA SLC12A1 KITLG SLC12A3 SLC22A8 CLCN6 FCGRT PROM2 NCOA1 KCNQ1 SLC14A2 G6PC1 SLC23A1 IL6 | 9.60e-06 | 1475 | 139 | 24 | ctd:C029297 |
| Drug | AC1Q646P | 9.85e-06 | 47 | 139 | 5 | CID000005673 | |
| Drug | Pro-val | 9.85e-06 | 47 | 139 | 5 | CID000142984 | |
| Drug | retigabine | 1.09e-05 | 48 | 139 | 5 | CID000121892 | |
| Drug | phloretin | 1.61e-05 | 131 | 139 | 7 | CID000004788 | |
| Drug | lacosamide | 1.63e-05 | 52 | 139 | 5 | CID000219078 | |
| Drug | oroxylin A | 2.09e-05 | 27 | 139 | 4 | CID005320315 | |
| Drug | TEMPOL-H | 2.59e-05 | 10 | 139 | 3 | ctd:C505333 | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; PC3; HT_HG-U133A | 2.71e-05 | 195 | 139 | 8 | 6339_DN | |
| Drug | Deferoxamine mesylate [138-14-7]; Down 200; 6uM; MCF7; HT_HG-U133A | 2.81e-05 | 196 | 139 | 8 | 3842_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.02e-05 | 198 | 139 | 8 | 6343_DN | |
| Drug | Probenecid | 3.03e-05 | 59 | 139 | 5 | ctd:D011339 | |
| Drug | Gly-His-Lys acetate salt; Up 200; 1uM; MCF7; HT_HG-U133A | 3.13e-05 | 199 | 139 | 8 | 6575_UP | |
| Drug | DiC8 | 3.25e-05 | 146 | 139 | 7 | CID000001323 | |
| Drug | Ado-5'-PP[S | 3.29e-05 | 60 | 139 | 5 | CID005310995 | |
| Drug | potassium | SLC4A1 SLC6A7 ADORA2B SLC7A4 ADO SLC12A1 SLC12A3 KCNQ5 CLCN6 CLCA2 KCNQ4 SCG2 KCNQ1 KCNQ2 KCNQ3 DLG4 NOS2 IL6 | 4.33e-05 | 1008 | 139 | 18 | CID000000813 |
| Drug | Rutin | 4.55e-05 | 105 | 139 | 6 | ctd:D012431 | |
| Drug | furosemide | 4.60e-05 | 272 | 139 | 9 | CID000003440 | |
| Drug | Mycotoxins | 6.04e-05 | 68 | 139 | 5 | ctd:D009183 | |
| Drug | diazoxide | 7.93e-05 | 227 | 139 | 8 | CID000003019 | |
| Drug | RP 55778 | 9.60e-05 | 15 | 139 | 3 | CID000121869 | |
| Drug | S-EBNA | 1.11e-04 | 3 | 139 | 2 | CID005311431 | |
| Drug | 12-dehydrogingerdione | 1.11e-04 | 3 | 139 | 2 | ctd:C587370 | |
| Drug | AC1Q504S | 1.11e-04 | 3 | 139 | 2 | CID000189847 | |
| Drug | Sizofiran | 1.11e-04 | 3 | 139 | 2 | ctd:D012566 | |
| Drug | methyl 3-isothiocyanatopropanoate | 1.11e-04 | 3 | 139 | 2 | CID000140454 | |
| Drug | 3-isoinosine | 1.11e-04 | 3 | 139 | 2 | CID000193428 | |
| Drug | eutigoside C | 1.11e-04 | 3 | 139 | 2 | ctd:C505499 | |
| Drug | CID6432277 | 1.13e-04 | 41 | 139 | 4 | CID006432277 | |
| Drug | sivelestat | 1.13e-04 | 41 | 139 | 4 | CID000107706 | |
| Drug | ferutinin | 1.18e-04 | 16 | 139 | 3 | CID000354654 | |
| Drug | Chlorides | 1.24e-04 | 42 | 139 | 4 | ctd:D002712 | |
| Drug | 9-OH-B220 | 1.31e-04 | 127 | 139 | 6 | CID000130705 | |
| Drug | NH4Cl | 1.40e-04 | 184 | 139 | 7 | CID000025517 | |
| Drug | metolazone | 1.42e-04 | 17 | 139 | 3 | CID000004170 | |
| Drug | Atorvastatin Calcium | 1.49e-04 | 186 | 139 | 7 | ctd:D000069059 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 1.49e-04 | 44 | 139 | 4 | ctd:C419410 | |
| Drug | Sodium | 1.65e-04 | 84 | 139 | 5 | ctd:D012964 | |
| Drug | rutecarpine | 1.70e-04 | 18 | 139 | 3 | ctd:C028632 | |
| Drug | Megestrol acetate [595-33-5]; Up 200; 10.4uM; HL60; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 3091_UP | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; HL60; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 3108_DN | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.00e-04 | 195 | 139 | 7 | 3800_UP | |
| Drug | AC1O5UZN | 2.01e-04 | 19 | 139 | 3 | CID006441264 | |
| Drug | iridoid | 2.01e-04 | 19 | 139 | 3 | CID000453214 | |
| Drug | sulfasalazine; Down 200; 100uM; MCF7; HG-U133A | 2.06e-04 | 196 | 139 | 7 | 204_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3940_DN | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3122_DN | |
| Drug | Ribostamycin sulfate salt [53797-35-6]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 2.13e-04 | 197 | 139 | 7 | 3444_DN | |
| Drug | RSVA405 | 2.20e-04 | 4 | 139 | 2 | ctd:C570843 | |
| Drug | RSVA314 | 2.20e-04 | 4 | 139 | 2 | ctd:C570842 | |
| Drug | diarctigenin | 2.20e-04 | 4 | 139 | 2 | ctd:C532887 | |
| Drug | praeruptorin E | 2.20e-04 | 4 | 139 | 2 | ctd:C036455 | |
| Drug | 3-(beta-D-ribofuranosyl)adenine | 2.20e-04 | 4 | 139 | 2 | CID000096631 | |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 199 | 139 | 7 | 5426_DN | |
| Drug | Acrylamide | 2.26e-04 | 199 | 139 | 7 | ctd:D020106 | |
| Disease | long QT syndrome (implicated_via_orthology) | 1.70e-12 | 10 | 135 | 6 | DOID:2843 (implicated_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 2.90e-07 | 13 | 135 | 4 | DOID:0112202 (implicated_via_orthology) | |
| Disease | heart conduction disease (implicated_via_orthology) | 1.36e-05 | 32 | 135 | 4 | DOID:10273 (implicated_via_orthology) | |
| Disease | Benign neonatal seizures | 2.08e-05 | 2 | 135 | 2 | cv:C0220669 | |
| Disease | benign neonatal seizures (implicated_via_orthology) | 2.08e-05 | 2 | 135 | 2 | DOID:14264 (implicated_via_orthology) | |
| Disease | mean corpuscular hemoglobin concentration | NUP50 IFT140 DPY19L3 POT1 ABCA7 SLC4A1 SLC9A4 KITLG CLCN6 SLC5A6 MRPL36 PRKDC UBE3C SLC23A1 PIGO S1PR4 | 4.75e-05 | 1105 | 135 | 16 | EFO_0004528 |
| Disease | otitis media (biomarker_via_orthology) | 6.08e-05 | 17 | 135 | 3 | DOID:10754 (biomarker_via_orthology) | |
| Disease | benign neonatal seizures (is_implicated_in) | 6.21e-05 | 3 | 135 | 2 | DOID:14264 (is_implicated_in) | |
| Disease | systolic blood pressure, alcohol consumption measurement | 6.42e-05 | 47 | 135 | 4 | EFO_0006335, EFO_0007878 | |
| Disease | mean arterial pressure, alcohol drinking | 8.99e-05 | 98 | 135 | 5 | EFO_0004329, EFO_0006340 | |
| Disease | mean arterial pressure, alcohol consumption measurement | 9.57e-05 | 52 | 135 | 4 | EFO_0006340, EFO_0007878 | |
| Disease | Renal tubular acidosis | 1.24e-04 | 4 | 135 | 2 | C0001126 | |
| Disease | Anencephaly | 1.24e-04 | 4 | 135 | 2 | C0002902 | |
| Disease | tartronate (hydroxymalonate) measurement | 1.24e-04 | 4 | 135 | 2 | EFO_0800944 | |
| Disease | Neural tube defect | 2.06e-04 | 5 | 135 | 2 | cv:C0027794 | |
| Disease | diastolic blood pressure, alcohol drinking | 2.15e-04 | 118 | 135 | 5 | EFO_0004329, EFO_0006336 | |
| Disease | Hyalinosis, Segmental Glomerular | 2.82e-04 | 28 | 135 | 3 | C0086432 | |
| Disease | Familial benign neonatal epilepsy | 3.08e-04 | 6 | 135 | 2 | C0220669 | |
| Disease | Spina bifida aperta of cervical spine | 3.08e-04 | 6 | 135 | 2 | C1960883 | |
| Disease | Developmental regression | 4.30e-04 | 7 | 135 | 2 | C1836830 | |
| Disease | Hyperuricemia | 4.30e-04 | 7 | 135 | 2 | C0740394 | |
| Disease | smoking status measurement, inflammatory bowel disease | 4.30e-04 | 7 | 135 | 2 | EFO_0003767, EFO_0006527 | |
| Disease | Sacral agenesis | 4.30e-04 | 7 | 135 | 2 | C0344490 | |
| Disease | lung disease (biomarker_via_orthology) | 5.51e-04 | 35 | 135 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | neural tube defect (is_implicated_in) | 5.71e-04 | 8 | 135 | 2 | DOID:0080074 (is_implicated_in) | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 5.71e-04 | 8 | 135 | 2 | C3891448 | |
| Disease | Focal glomerulosclerosis | 5.99e-04 | 36 | 135 | 3 | C0017668 | |
| Disease | neural tube defect (implicated_via_orthology) | 7.32e-04 | 9 | 135 | 2 | DOID:0080074 (implicated_via_orthology) | |
| Disease | Malignant tumor of colon | 8.42e-04 | 159 | 135 | 5 | C0007102 | |
| Disease | threonate measurement | 9.13e-04 | 10 | 135 | 2 | EFO_0021032 | |
| Disease | Diuretic use measurement | 1.11e-03 | 169 | 135 | 5 | EFO_0009928 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 1.33e-03 | 12 | 135 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Malignant neoplasm of breast | CDS1 UTS2R HK3 NUP214 TMEM161A CLCA2 DDX18 NCOA1 GKN1 G6PC1 NOS2 IL6 NOTCH1 | 1.33e-03 | 1074 | 135 | 13 | C0006142 |
| Disease | lung disease (implicated_via_orthology) | 1.57e-03 | 13 | 135 | 2 | DOID:850 (implicated_via_orthology) | |
| Disease | ascorbic acid 2-sulfate measurement | 1.57e-03 | 13 | 135 | 2 | EFO_0800169 | |
| Disease | Leishmaniasis, Visceral | 1.57e-03 | 13 | 135 | 2 | C0023290 | |
| Disease | hyperglycemia (is_marker_for) | 1.57e-03 | 13 | 135 | 2 | DOID:4195 (is_marker_for) | |
| Disease | iron deficiency anemia (biomarker_via_orthology) | 1.57e-03 | 13 | 135 | 2 | DOID:11758 (biomarker_via_orthology) | |
| Disease | Cholestasis | 1.66e-03 | 110 | 135 | 4 | C0008370 | |
| Disease | ascorbic acid 3-sulfate measurement | 1.82e-03 | 14 | 135 | 2 | EFO_0800173 | |
| Disease | neuronal ceroid lipofuscinosis (implicated_via_orthology) | 1.82e-03 | 14 | 135 | 2 | DOID:14503 (implicated_via_orthology) | |
| Disease | familial atrial fibrillation (is_implicated_in) | 1.82e-03 | 14 | 135 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | Beta blocking agent use measurement | 1.90e-03 | 114 | 135 | 4 | EFO_0009929 | |
| Disease | Acute Cerebrovascular Accidents | 1.96e-03 | 54 | 135 | 3 | C0751956 | |
| Disease | glycerate measurement | 2.10e-03 | 15 | 135 | 2 | EFO_0021029 | |
| Disease | cutaneous psoriasis measurement, psoriasis | 2.39e-03 | 16 | 135 | 2 | EFO_0000676, EFO_0007773 | |
| Disease | Malaria, susceptibility to | 2.39e-03 | 16 | 135 | 2 | cv:C1970028 | |
| Disease | vitamin C measurement | 2.39e-03 | 16 | 135 | 2 | EFO_0600003 | |
| Disease | – | 2.39e-03 | 16 | 135 | 2 | 611162 | |
| Disease | response to acetylsalicylate | 2.39e-03 | 16 | 135 | 2 | GO_1903492 | |
| Disease | Glycogen storage disease | 2.70e-03 | 17 | 135 | 2 | cv:C0017919 | |
| Disease | Necrotizing Enterocolitis | 2.70e-03 | 17 | 135 | 2 | C0520459 | |
| Disease | Cerebrovascular accident | 2.91e-03 | 62 | 135 | 3 | C0038454 | |
| Disease | nevus count | 3.03e-03 | 18 | 135 | 2 | EFO_0004632 | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.18e-03 | 64 | 135 | 3 | DOID:4947 (is_marker_for) | |
| Disease | stroke, major depressive disorder | 3.38e-03 | 19 | 135 | 2 | EFO_0000712, MONDO_0002009 | |
| Disease | lymphocyte percentage of leukocytes | 3.60e-03 | 665 | 135 | 9 | EFO_0007993 | |
| Disease | Malaria | 3.74e-03 | 20 | 135 | 2 | C0024530 | |
| Disease | neutrophil count, basophil count | 3.76e-03 | 224 | 135 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | systemic lupus erythematosus | 3.79e-03 | 799 | 135 | 10 | MONDO_0007915 | |
| Disease | Nephritis, Tubulointerstitial | 4.12e-03 | 21 | 135 | 2 | C0041349 | |
| Disease | Noise-induced hearing loss | 4.52e-03 | 22 | 135 | 2 | C0018781 | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 4.52e-03 | 22 | 135 | 2 | C1843687 | |
| Disease | complement factor H-like 1 protein measurement | 4.52e-03 | 22 | 135 | 2 | EFO_0600092 | |
| Disease | impotence (biomarker_via_orthology) | 4.52e-03 | 22 | 135 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | Leber Congenital Amaurosis | 4.52e-03 | 22 | 135 | 2 | C0339527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ASFLGLLVFLTPIAF | 116 | Q8TAA9 | |
| AGATLALLSFLTPLA | 111 | Q9ULK5 | |
| LALTLPFAAAGALQG | 91 | P46092 | |
| LPLSIFASLGNLTFL | 256 | P22792 | |
| SIALSTFASLIGPFG | 356 | Q92903 | |
| FALLGAQPLLVVGFS | 451 | P02730 | |
| VGLFAIPFAITISLG | 56 | P29275 | |
| SLGAEPGSLLFLQSA | 1621 | Q86V15 | |
| FSLGVFLLKSGTSIP | 96 | Q96SZ5 | |
| LAGSIFSFGILPLVF | 36 | Q4VNC1 | |
| GASSFFPLVVLLLAG | 6 | P36896 | |
| ALSTFASLIGPFGGF | 341 | O95674 | |
| VPVAGTLAFGLLTAF | 366 | O43246 | |
| FGLLPFNTFGRLSDT | 401 | Q6ZPD9 | |
| TLGALSTPFAFRIQG | 61 | Q9HBB8 | |
| RVAASLLSPVAFGFG | 686 | Q8IZY2 | |
| VLGSLSSVPLTGFSF | 281 | Q9UKX7 | |
| FALIDFVNPGILGSL | 471 | Q9Y620 | |
| LTFAFIIGLDGSTGP | 81 | Q8NFJ5 | |
| SSATLLAPLLSGLFV | 406 | Q6ZVN8 | |
| SAFIFLVSVLGGAPG | 26 | Q6ZRI8 | |
| LGISFSFPGLKSLLV | 781 | P20702 | |
| LTLSGGPSALAFDLS | 96 | Q9BUH6 | |
| NGLAAAGSPVFLSAL | 146 | O95907 | |
| FPSLRVSAGFLLSQL | 886 | P35228 | |
| ILSSYFRLSLGGISP | 236 | Q5HYI7 | |
| LSPALTFAIAGLGSG | 106 | Q9BQT8 | |
| AFSGLTALPRSILLF | 511 | Q5HY92 | |
| AISFFALPAGILGSG | 336 | P51787 | |
| AFLGALASLGSLNIP | 1701 | P46531 | |
| LGLTDGSLVFLPFDT | 266 | Q02846 | |
| PTLLLATLSAAFGSA | 21 | Q6PXP3 | |
| LLFGLLGPSSENTTA | 16 | E2RYF6 | |
| LGGAPSSASFLLQEL | 651 | Q5IJ48 | |
| FTLAVSAGAVLLLPF | 66 | Q8WVP7 | |
| LLLVPGGFFGVSAAT | 221 | Q9HAT1 | |
| FSLIGVSFFALPAGI | 336 | O43525 | |
| VSFFALPAGILGSGL | 341 | O43525 | |
| LLSAGFALLGISFFA | 326 | Q9NR82 | |
| FALLGISFFALPAGI | 331 | Q9NR82 | |
| ISFFALPAGILGSGF | 336 | Q9NR82 | |
| AGFALLGISFFALPA | 301 | P56696 | |
| LGISFFALPAGILGS | 306 | P56696 | |
| LSPLIFLALSLNGFG | 131 | O75387 | |
| LTLTHFGLLASPFLS | 371 | Q53F39 | |
| FGLLASPFLSGLNLL | 376 | Q53F39 | |
| FLLPGSLGAESHLSL | 16 | P55899 | |
| AAFLAPGTLLGVFAA | 291 | Q9ULL4 | |
| TFTLIGVSFFALPAG | 296 | O43526 | |
| SAGPFLLTGFLGSEA | 6 | Q9Y5P0 | |
| LILTSRGPGTSFEFA | 151 | Q99497 | |
| LLFLGGPASSAYALS | 46 | Q9Y4A8 | |
| DFLSPSGGARLASLF | 11 | Q5T1M5 | |
| SLSGSQGIFPLAFFI | 16 | Q9UM44 | |
| LFPSSLAGETLGSFS | 1321 | P35658 | |
| FPSFLSGLALLSVLL | 236 | Q96S97 | |
| GLLGSFNSDLVTLPL | 556 | Q13651 | |
| LLLGTGKSPRQSLFF | 361 | P15289 | |
| LPLGLTGAFEDTSFA | 166 | Q9NVP1 | |
| GLLFGADATLLQSPV | 226 | Q0VG06 | |
| GLSGQSLPLGFTFSF | 596 | P52790 | |
| ALTLLSGSSGAFIPV | 461 | Q9Y3T9 | |
| SLGLEATLPFRLNGF | 401 | Q9Y5I4 | |
| FASSVFGAIPLSGII | 201 | Q8NGA0 | |
| LAIGVFLFPAFLTAS | 246 | P55085 | |
| NAGFIAPLFTVTLLG | 116 | Q9P2N4 | |
| AAAFGAPIGGTLFSL | 251 | P51797 | |
| VFAGLLGVFLAPALA | 6 | Q9NS71 | |
| GSLFPSFLLLACGTL | 11 | A1L0T0 | |
| FILLPSVFGVSLGIS | 21 | Q53EU6 | |
| LLSAPLGSGGFTLLH | 526 | Q9H8Y5 | |
| TPFASLLKNLGTLFG | 256 | P35575 | |
| TFTGYSALALALALP | 111 | Q86VU5 | |
| IFISFILAGGPADLS | 336 | P78352 | |
| GPFFFIISGSLSIAT | 91 | Q9H2W1 | |
| SGAPLGLSTFLGAAV | 456 | Q96QS3 | |
| SLGPAFASGLLLSSA | 861 | Q8TEH3 | |
| LLVASLAGAFGSSFL | 56 | Q9NRM0 | |
| AGLLFFLAGTVSLSP | 136 | P56749 | |
| FLLLATLFSALTGLP | 126 | O75844 | |
| TALLGGSAALFLPET | 481 | Q8TCC7 | |
| SLPFIVFGATGLTSG | 461 | Q8IZD6 | |
| PLFGLLLADVFGSNL | 266 | O95977 | |
| IILNAGFFGFSLTPD | 2916 | Q6ZTR5 | |
| GFFGFSLTPDLTEVL | 2921 | Q6ZTR5 | |
| AGPAADVLILSFFIS | 686 | Q96RY7 | |
| LLASSLLFAGLSAVP | 11 | O95965 | |
| TSAFGPVAFSLGLLL | 6 | P05231 | |
| DAGLLSIISFPAFAV | 256 | P46019 | |
| ALLSAGPFLFLVGVE | 166 | O43193 | |
| GLEGFSIAFLSPIFL | 41 | Q9H720 | |
| LLLSGLAVFFLFPRS | 106 | Q9NUM4 | |
| LSTFLFGSIRGAAPV | 26 | Q9P0J6 | |
| IFGNAVSLILGLTPF | 501 | Q8N3S3 | |
| LLGELSFFSSGIDVP | 406 | Q9NQ86 | |
| FLLGSVLNVLFAPGS | 16 | Q504Y2 | |
| LAVVGSVLGAFLTFP | 231 | Q9NX61 | |
| SVLGAFLTFPGLRLA | 236 | Q9NX61 | |
| LFGLLSSPLSSLARF | 71 | O76081 | |
| LPGLFIACLFSGSLS | 351 | Q9Y289 | |
| SLGPLLLEALDGFFF | 111 | Q15788 | |
| FASLTFEGTLGAPII | 101 | Q9NUX5 | |
| GFTFLLSAGLLLLPA | 416 | Q7Z3Q1 | |
| IPLIFLISGAEAASF | 16 | P13521 | |
| GAGSFSLAFLLPLSL | 431 | Q6AI14 | |
| GLFALGILVPFANSI | 426 | Q8N695 | |
| GFGPLITAGIFSATL | 491 | Q13621 | |
| SFAVGSSSGLLPLLL | 956 | Q9UL54 | |
| PALFSLIIGFAFGAL | 221 | P21583 | |
| LRLNFSLVGTPLSAF | 731 | P11215 | |
| SLLTQPIFLAGLSGF | 491 | Q6PIS1 | |
| PIFLAGLSGFLLENT | 496 | Q6PIS1 | |
| FFLELSLGQFSSLGP | 91 | Q99884 | |
| PTGYLGALASALFTA | 166 | P54922 | |
| GSVFSLGLPLATALA | 291 | Q99788 | |
| ALSSELPFLGAGVQL | 21 | Q9UQC9 | |
| TFLLRLFGPGFANSS | 61 | Q8NE01 | |
| SGFFLFGSPLGLVLA | 691 | O00562 | |
| VPFGLAAFATTLFAL | 196 | Q9H6R6 | |
| AAFATTLFALGLALG | 201 | Q9H6R6 | |
| AFSLTGLSLFFSLVP | 11 | O60939 | |
| ASFPGFLFVLLGVGS | 146 | Q96BF3 | |
| ASGSPLLILTFLGFV | 331 | Q9NRZ7 | |
| FTSGALAPLAFSVLP | 316 | Q7RTY0 | |
| LLSGSGILLTLPHFF | 381 | Q7RTY0 | |
| LSLPVIGSAAERGFF | 166 | Q13064 | |
| FSGTIAVPFLLAEAL | 56 | Q9UHI7 | |
| AGVGLSFLFAAPLIL | 476 | Q8N271 | |
| ALSGFGLPLASQEAL | 131 | P04844 | |
| TGLLGSAPFLFLSLA | 361 | Q9H2V7 | |
| SLLFALFLAASLGPV | 16 | Q9H7M9 | |
| GFLVSGLFSIISSIP | 261 | Q9NPD5 | |
| ALQSILSIAGGDPLF | 486 | Q6ZS81 | |
| GSLPFFLLVGFAGAI | 216 | O75631 | |
| SGFAPLITAGIFGAT | 451 | P55017 | |
| GSASPFPFLTALLSL | 886 | Q9BWH6 | |
| LPFFTSLTGGSLEEL | 1696 | P78527 | |
| SALAAILGAVPFLGT | 741 | Q9H330 | |
| YLTLLFATSIAGPGL | 211 | Q9UKP6 | |
| GFQLSFASSGPSVLL | 66 | O95789 | |
| VLLGAVAAVSSFLPF | 511 | Q8TEQ8 | |
| VLLLFAFSLPGSRAS | 26 | Q8IYR6 | |
| TFAIPGSIFLSILSG | 126 | Q5BJD5 | |
| GVSSAIFFVPGFLLL | 151 | Q9H6X4 | |
| FPLTATLGLAGFTLL | 221 | Q9BVT8 | |
| TGGVFLVALFISSPL | 301 | Q15849 | |
| VLSFLTSLVTGFPSG | 1376 | Q562E7 | |
| ELPFAGFFLSKLLGT | 836 | Q15386 | |
| QLGDLFASFLPGIST | 201 | O43156 | |
| GASFLKIFGPLSSSA | 36 | O60635 |